Nonalcoholic fatty liver disease, diet and gut microbiota
Loading...
Date
2014-05-07
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a severe liver disease that is increasing in prevalence with the worldwide epidemic of obesity and its related insulin-resistance state. Evidence for the role of the gut
microbiota in energy storage and the subsequent development of obesity and some of its related diseases is now well established. More recently, a new role of gut microbiota has emerged in NAFLD. The gut microbiota is involved in gut permeability, low-grade inflammation and immune balance, it modulates dietary choline metabolism, regulates bile acid metabolism and produces endogenous ethanol. All of these factors are molecular mechanisms by which the microbiota can induce NAFLD or its progression toward overt nonalcoholic steatohepatitis. Modification of the gut microbiota composition and/or its biochemical capacity by specific dietary or pharmacological
interventions may advantageously affect host metabolism. Large-scale intervention trials,
investigating the potential benefit of prebiotics and probiotics in improving
cardiometabolic health in high-risk populations, are fervently awaited.
Description
Table of contents
Keywords
Gut microbiome, NAFLD, interventions